Investigation serum procalcitonin in patients with exacerbation of obstructive pulmonary disease

Document Type : Original Article


1 Residency of internal medicine, School of medicine, Mashhad University of Medical sciences, Mashhad, Iran.

2 Pulmonologist, Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Internist, Department of Internal medicine, Faculty of Medicine, Mashhad University of Medical sciences, Mashhad, Iran.

4 Community Medicine, Department of Community Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Introduction: Chronic obstructive pulmonary disease (COPD) is a disease of chronic diffuse irreversible airflow obstruction. Due to the relatively high prevalence of the disease, paying attention to the treatment of these patients helps a lot in controlling the disease and reducing its cost. This study aimed to investigate the presence of serum procalcitonin in patients with an acute attack of COPD.
Methods & Materials: This cross-sectional study was performed on 65 patients with an acute COPD attack in Imam Reza Hospital in 2019 by the convenience sampling method. Three ccs of blood samples were taken from patients to check serum procalcitonin levels from hospitalization to 24 hours after that. Patients with an acute COPD attack were selected based on American thoracic society criteria. Also, demographic information such as age, sex, hospitalization time, and duration of the disease was recorded. Patient complaints, disease exacerbation, and type of ventilation were recorded. Data were analyzed with SPSS software (version 16). Man-Whitney and Kruskal Wallis tests were used to analyze the data. The significance level was Results: According to data, 65 patients (36 men and 29 women) were examined and the mean age of the patients was 66.72 (±12.65) years. Dyspnea was the most common complaint in patients. Serum procalcitonin levels were higher in patients with invasive ventilation (P = 0.007). Also, serum procalcitonin levels were lower in patients with non-invasive ventilation (P = 0.008). Besides, serum procalcitonin levels increase with increasing disease exacerbation from mild to moderate (P <0.001). According to the results of the post hoc test, there was a significant difference between mild and severe (P <0.001) and moderate and severe groups (P <0.001). There is also a significant correlation between procalcitonin serum levels and Exacerbation (R=0.6, P <0.001) and age (R=0.2, P = 0.01). serum procalcitonin levels were higher in patients with the use of invasive ventilation
Conclusion: According to the results, serum procalcitonin levels are associated with acute COPD attacks. Measurement of procalcitonin levels in patients with acute COPD attacks can help diagnose and perform timely care.


Mitzner W. Emphysema: a disease of small airways or lung parenchyma? The New England journal of medicine. 2011;365(17):1637.
2.             Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. American journal of respiratory and critical care medicine. 2017;195(5):557-82.
3.             Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine: Mcgraw-hill New York; 2012.
4.             Rammaert B, Verdier N, Cavestri B, Nseir S. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2009;14(7):969-74.
5.             O’Donnell DE, Laveneziana P, Webb K, Neder JA. Chronic obstructive pulmonary disease: clinical integrative physiology. Clinics in chest medicine. 2014;35(1):51-69.
6.             Chang C-H, Tsao K-C, Hu H-C, Huang C-C, Kao K-C, Chen N-H, et al. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits. International journal of chronic obstructive pulmonary disease. 2015;10:767.
7.             Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC pulmonary medicine. 2011;11(1):36.
8.             Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sørensen M, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. American journal of respiratory and critical care medicine. 2011;183(4):455-61.
9.             Ergan B, Şahin AA, Topeli A. Serum procalcitonin as a biomarker for the prediction of bacterial exacerbation and mortality in severe COPD exacerbations requiring mechanical ventilation. Respiration. 2016;91(4):316-24.
10.          Daubin C, Parienti J-J, Vabret A, Ramakers M, Fradin S, Terzi N, et al. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC infectious diseases. 2008;8(1):145.
11.          Vagaggini B, Costa F, Antonelli S, De Simone C, De Cusatis G, Martino F, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respiratory medicine. 2009;103(8):1224-30.
12.          Li Y, Xie L, Xin S, Li K. Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection. Pakistan journal of medical sciences. 2017;33(3):566.
13.          Giorgi-Pierfranceschi M, Cravo J, Dentali F, Esquinas AM. Is Procalcitonin Really Useful for Diagnosis and Prognosis of COPD Exacerbations Requiring Mechanical Ventilation? Respiration. 2017;93(2):151-2.
14.          Ebrahimzadeh F, Rezaeetalab F, Matoofi A. The Relationship between Serum N-terminal Pro B-type Natriuretic Peptide Level and the Severity of Chronic Obstructive Pulmonary Disease Exacerbation. 2018.
15.          Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest. 2007;131(4):1058-67.